128 related articles for article (PubMed ID: 16964710)
21. Comparison of polyethylene glycol and polyoxyethylene stearate as excipients for solid dispersion systems of griseofulvin and tolbutamide I: phase equilibria.
Kaur R; Grant DJ; Eaves T
J Pharm Sci; 1980 Nov; 69(11):1317-21. PubMed ID: 7452463
[TBL] [Abstract][Full Text] [Related]
22. Characterization and stability of solid dispersions based on PEG/polymer blends.
Bley H; Fussnegger B; Bodmeier R
Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
[TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization and in vitro dissolution studies of solid dispersion of meloxicam with PEG 6000.
Vijaya Kumar SG; Mishra DN
Yakugaku Zasshi; 2006 Aug; 126(8):657-64. PubMed ID: 16880724
[TBL] [Abstract][Full Text] [Related]
24. Sylysia 350/Eudragit S100 solid nanomatrix as a promising system for oral delivery of cyclosporine A.
Dai W; Guo Y; Zhang H; Wang X; Zhang Q
Int J Pharm; 2015 Jan; 478(2):718-25. PubMed ID: 25448562
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
26. Solid dispersions of nimodipine and polyethylene glycol 2000: dissolution properties and physico-chemical characterisation.
Urbanetz NA; Lippold BC
Eur J Pharm Biopharm; 2005 Jan; 59(1):107-18. PubMed ID: 15567307
[TBL] [Abstract][Full Text] [Related]
27. Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note.
Kumar S; Gupta SK
Arch Pharm Res; 2014 Mar; 37(3):340-51. PubMed ID: 23674128
[TBL] [Abstract][Full Text] [Related]
28. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
[TBL] [Abstract][Full Text] [Related]
29. Enhanced release of solid dispersions of etodolac in polyethylene glycol.
Ozkan Y; Doganay N; Dikmen N; Işimer A
Farmaco; 2000; 55(6-7):433-8. PubMed ID: 11204743
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
31. Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement.
Hu XY; Lou H; Hageman MJ
Int J Pharm; 2018 Dec; 552(1-2):154-163. PubMed ID: 30268849
[TBL] [Abstract][Full Text] [Related]
32. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the microstructure of semicrystalline solid dispersions.
Zhu Q; Taylor LS; Harris MT
Mol Pharm; 2010 Aug; 7(4):1291-300. PubMed ID: 20550195
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a cyclosporine solid dispersion for inhalation.
Zijlstra GS; Rijkeboer M; Jan van Drooge D; Sutter M; Jiskoot W; van de Weert M; Hinrichs WL; Frijlink HW
AAPS J; 2007 Jun; 9(2):E190-9. PubMed ID: 17614361
[TBL] [Abstract][Full Text] [Related]
35. Preparation, physicochemical characterization and drug release studies of albendazole solid dispersions.
Mallick S; Sahoo A; Mitra SS
Boll Chim Farm; 2003 May; 142(4):180-6. PubMed ID: 12918228
[TBL] [Abstract][Full Text] [Related]
36. A comparison of the effect of temperature and moisture on the solid dispersions: aging and crystallization.
Tian B; Zhang L; Pan Z; Gou J; Zhang Y; Tang X
Int J Pharm; 2014 Nov; 475(1-2):385-92. PubMed ID: 25218489
[TBL] [Abstract][Full Text] [Related]
37. Crystallinity and dissolution rate of tolbutamide solid dispersions prepared by the melt method.
McGinity JW; Maincent P; Steinfink H
J Pharm Sci; 1984 Oct; 73(10):1441-4. PubMed ID: 6502495
[TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of azithromycin--Aerosil 200 solid dispersions with enhanced physical stability.
Li X; Peng H; Tian B; Gou J; Yao Q; Tao X; He H; Zhang Y; Tang X; Cai C
Int J Pharm; 2015; 486(1-2):175-84. PubMed ID: 25794608
[TBL] [Abstract][Full Text] [Related]
39. The use of a new hydrophilic polymer, Kollicoat IR, in the formulation of solid dispersions of Itraconazole.
Janssens S; de Armas HN; Remon JP; Van den Mooter G
Eur J Pharm Sci; 2007 Mar; 30(3-4):288-94. PubMed ID: 17204410
[TBL] [Abstract][Full Text] [Related]
40. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
Ozdemir N; Ordu S
Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
